Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer

NCT00399035 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1254

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Cediranib
DRUG: FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin)
DRUG: XELOX (Capecitabine and Oxaliplatin)
DRUG: Cediranib Placebo

Sponsor

AstraZeneca